Skip to content
Menu

Aptevo Therapeutics Inc. APVO

Full chart Compare
Set alert

Price alert · APVO

All alert types
0.60 USD 0.00 (+0.29%)

As ofNov 16, 2026, 10:21 AM EST

0.5901 Day range 0.6055
0.5901 52-week range 25.65
YTD
-93.68%
1 year
-97.65%

Revenue & Expenses

Revenue Profit Costs
Other Income$36.67MGross Profit$3.11MGross Profit & Other Income$39.78MNet Income$8.03MSelling, General & Admin$13.87MResearch & Development$17.88MRevenue$3.11M

Latest period ending Dec 31, 2025 · select a line to chart its full history

APVO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-26.31M-24.60M-28.88M-28.64M-21.40M
-25.97M-24.13M-17.41M8.03M-28.46M
-87.27-31,460.23-834,059.00920,146.00-3,557,506.00
APVO annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
21.62M8.71M16.90M22.64M46.30M
27.19M15.59M24.84M34.22M56.60M
9.81M10.84M12.62M16.24M55.38M
4.63M5.40M5.40M9.54M16.71M
17.38M4.75M12.22M17.97M1.22M
APVO annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-25.59M-23.79M-11.73M-21.02M-21.68M
38.50M15.60M6.00M-2.62M26.16M
12.90M-8.19M-5.73M-23.67M3.77M